2022
DOI: 10.3389/fcvm.2022.900810
|View full text |Cite
|
Sign up to set email alerts
|

Dominant Myocardial Fibrosis and Complex Immune Microenvironment Jointly Shape the Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy

Abstract: BackgroundArrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable life-threatening myocardial disease characterized by ventricular arrhythmias and sudden cardiac death. Few studies used RNA-sequencing (RNA-seq) technology to analyze gene expression profiles, hub genes, dominant pathogenic processes, immune microenvironment in ARVC. This study aimed to explore these questions via integrated bioinformatics analysis.MethodsRNA-sequencing datasets of GSE107475, GSE107311, GSE107156, and GSE107125 wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 66 publications
0
2
0
Order By: Relevance
“…It was stated that the increase of intrafasicular connective tissue usually represent a response to a loss of cardiomyocytes where fibroblasts replace the damaged area, with subsequent formation of collagen fibers [31] . Furthermore, Lu et al [32] reported a positive linear correlation between myocardial fibrosis activity and immune cell infiltration.…”
Section: Discussionmentioning
confidence: 97%
“…It was stated that the increase of intrafasicular connective tissue usually represent a response to a loss of cardiomyocytes where fibroblasts replace the damaged area, with subsequent formation of collagen fibers [31] . Furthermore, Lu et al [32] reported a positive linear correlation between myocardial fibrosis activity and immune cell infiltration.…”
Section: Discussionmentioning
confidence: 97%
“…The potential underlying mechanism is related to expression of ATPase, NCX, ryanodine receptor 2 (RyR2) phosphorylation and CaMKII-RyR2 signaling activation triggered by MIF, which can be attenuated by blocking CD74 ( Figure 5 ) ( 93 ). In additional, bioinformatic analysis of the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) versus normal controls revealed an immune-related hub module, which Protein-Protein Interaction Network analysis identified CD74 as one of the most important hub genes ( 94 ). This information suggests that MIF/CD74 signaling is a potential therapeutic intervention for arrhythmia.…”
Section: The Role Of Cd74 In Cardiovascular Diseasesmentioning
confidence: 99%